Related Experiment Video
Updated: Jun 10, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
[Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism
1Klinik für Rheumatologie und Klinische Immunologie, Klinikum Bad Bramstedt, Oskar-Alexander-Str. 26, 24576, Bad Bramstedt, Deutschland. holle@klinikumbb.de
Insights
Vasculitis classification is evolving based on vessel size, symptoms, and histology. Current European guidelines offer evidence-based management strategies for different disease stages.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Vasculitis classification is based on American College of Rheumatology and Chapel Hill Consensus criteria.
- Diagnostic criteria are under development, incorporating vessel size, clinical, and histological findings.
- Understanding vasculitis subtypes is crucial for accurate diagnosis and treatment.
Framework:
- Current classification relies on inflamed blood vessel size (e.g., large vessel vasculitis).
- Clinical symptoms (e.g., cephalalgia in giant cell arteritis) and histological data are key components.
- Standardized diagnostic criteria are essential for consistent patient management.
Implementation:
- Disease stages and activity levels are now defined, guiding treatment.
- Controlled trials have informed evidence-based, stage-adapted therapy regimens.
- European League Against Rheumatism (EULAR) published management recommendations in 2009.
Implications:
- This review synthesizes current vasculitis classification systems.
- It summarizes European guidelines for effective vasculitis management.
- Standardized approaches improve patient outcomes in vasculitis.
Abstract:
Vasculitis is still being classified according the criteria of the American College of Rheumatology and the Chapel Hill Consensus Conference Definitions. Diagnostic criteria are currently being established. The classification criteria are based on the size of the inflamed blood vessel (e.g. large vessel vasculitis with inflammation of the aorta and its branches), clinical symptoms and findings (such as cephalalgia in giant cell arteritis) and histological findings. In recent years a definition of disease stages and activity has been established and a number of controlled trials have been carried out in order to provide evidence-based stage and activity adapted therapy regimens. Recommendations for the management of vasculitis have been published in 2009 by EULAR (European League Against Rheumatism). This article gives a review of the classification of vasculitis and summarizes the current European guidelines on management.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Rheumatic Heart Disease III: Medical Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
